MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.
Blankson
J N
JN
Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland, USA.
Siliciano
R F
RF
D000956:Antigens, Viral / Q000276:immunology; D023241:Antiretroviral Therapy, Highly Active; D000939:Epitopes / Q000276:immunology; D005802:Genes, MHC Class II; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000254:growth & development / Q000276:immunology*; D006801:Humans; D011110:Polymorphism, Genetic; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014766:Viremia / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D014779:Virus Replication
D000956:Antigens, Viral; D000939:Epitopes